Smithfield Trust’s DexCom DXCM Stock Holding History

Smithfield Trust’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6K	Sell	80 -2,350	-97%	-$157K	﹤0.01%	964
2026 Q1	$151K	Buy	2,430 +2,350	+2,938%	+$164K	0.01%	416
2025 Q4	$6K	Hold	80	–	–	﹤0.01%	958
2025 Q3	$6K	Hold	80	–	–	﹤0.01%	931
2025 Q2	$6K	Hold	80	–	–	﹤0.01%	939
2025 Q1	$6K	Hold	80	–	–	﹤0.01%	941
2024 Q4	$6K	Hold	80	–	–	﹤0.01%	954
2024 Q3	$6K	Hold	80	–	–	﹤0.01%	917
2024 Q2	$10K	Sell	80 -245	-75%	-$31K	﹤0.01%	815
2024 Q1	$46K	Hold	325	–	–	﹤0.01%	576
2023 Q4	$40K	Buy	325 +165	+103%	+$16.9K	﹤0.01%	582
2023 Q3	$15K	Hold	160	–	–	﹤0.01%	740
2023 Q2	$20K	Hold	160	–	–	﹤0.01%	693
2023 Q1	$19K	Hold	160	–	–	﹤0.01%	673
2022 Q4	$19K	Hold	160	–	–	﹤0.01%	656
2022 Q3	$12K	Hold	160	–	–	﹤0.01%	733
2022 Q2	$12K	Hold	160	–	–	﹤0.01%	774
2022 Q1	$20K	Hold	160	–	–	﹤0.01%	700
2021 Q4	$21K	Hold	160	–	–	﹤0.01%	700
2021 Q3	$21K	Hold	160	–	–	﹤0.01%	702
2021 Q2	$17K	Hold	160	–	–	﹤0.01%	726
2021 Q1	$14K	Hold	160	–	–	﹤0.01%	769
2020 Q4	$15K	Sell	160 -2,080	-93%	-$186K	﹤0.01%	732
2020 Q3	$231K	Hold	2,240	–	–	0.02%	259
2020 Q2	$227K	Buy	2,240 +1,200	+115%	+$107K	0.02%	255
2020 Q1	$70K	Buy	+1,040	New	+$64.7K	0.01%	390

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Smithfield Trust's DXCM Position: Q2 2026 in Review

Smithfield Trust reduced its DexCom (DXCM) stake by 97% in Q2 2026, selling an estimated $157K and leaving 80 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #964.

Smithfield Trust first reported a position in DXCM in Q1 2020 and has held it in 26 quarters since. The position peaked at $231K in Q3 2020. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Smithfield Trust held 80 shares of DexCom worth $6K as of Q2 2026.
Smithfield Trust sold 2,350 DexCom shares in Q2 2026, an estimated $157K.
DexCom made up ﹤0.01% of Smithfield Trust's portfolio in Q2 2026, its #964 holding.
Smithfield Trust first reported a position in DexCom in Q1 2020 and has held it in 26 quarters since.
Smithfield Trust's DexCom position peaked at $231K in Q3 2020.
973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Smithfield Trust's 13F filing for Q2 2026, filed 5 Aug 2026.